Stoke Therapeutics Inc.

NASDAQ: STOK · Real-Time Price · USD
9.64
0.28 (2.99%)
At close: May 12, 2025, 3:59 PM
9.62
-0.21%
After-hours: May 12, 2025, 06:45 PM EDT

Stoke Therapeutics Revenue

Stoke Therapeutics reported an annual revenue of $36.55M, reflecting a 316.34% growth. For the quarter ending December 31, 2024, Stoke Therapeutics generated $22.61M in revenue.
Revenue (ttm)
$36.55M
Revenue Growth
316.34%
Price / Sales Ratio
16.3
Revenue / Employee
$285.59K
Employees
128
Market Cap
526.31M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.